Details of the Drug

General Information of Drug (ID: DMY7WH1)

Drug Name
Sutimlimab
Indication
Disease Entry ICD 11 Status REF
Cold type autoimmune haemolytic anemia 3A20.1 Approved [1]
Affected Organisms
Humans and other mammals
ATC Code
L04AA55: Sutimlimab
L04AA: Selective immunosuppressants
L04A: IMMUNOSUPPRESSANTS
L04: IMMUNOSUPPRESSANTS
L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Drug Type
Antibody
Cross-matching ID
UNII
GNWE7KJ995
DrugBank ID
DB14996
TTD ID
DJ0L4K

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Complement C1s component (C1S) TT7LRQH C1S_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Cold type autoimmune haemolytic anemia
ICD Disease Classification 3A20.1
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Complement C1s component (C1S) DTT C1S 5.50E-01 1.09 0.91
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 FDA Approved Drug Products from FDA Official Website. 2023. Application Number: 761164.
2 Antibodies to watch in 2020. MAbs. Jan-Dec 2020;12(1):1703531.